155 related articles for article (PubMed ID: 8810053)
1. Effect of Saccharomyces boulardii against experimental oral infection with Salmonella typhimurium and Shigella flexneri in conventional and gnotobiotic mice.
Rodrigues AC; Nardi RM; Bambirra EA; Vieira EC; Nicoli JR
J Appl Bacteriol; 1996 Sep; 81(3):251-6. PubMed ID: 8810053
[TBL] [Abstract][Full Text] [Related]
2. Antagonistic effect of Lactobacillus acidophilus, Saccharomyces boulardii and Escherichia coli combinations against experimental infections with Shigella flexneri and Salmonella enteritidis subsp. typhimurium in gnotobiotic mice.
Filho-Lima JV; Vieira EC; Nicoli JR
J Appl Microbiol; 2000 Mar; 88(3):365-70. PubMed ID: 10747216
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of bifidus milk on the experimental infection with Salmonella enteritidis subsp. typhimurium in conventional and gnotobiotic mice.
Silva AM; Bambirra EA; Oliveira AL; Souza PP; Gomes DA; Vieira EC; Nicoli JR
J Appl Microbiol; 1999 Feb; 86(2):331-6. PubMed ID: 10063632
[TBL] [Abstract][Full Text] [Related]
4. [Comparative effect of a single or continuous administration of "Saccharomyces boulardii" on the establishment of various strains of "candida" in the digestive tract of gnotobiotic mice].
Ducluzeau R; Bensaada M
Ann Microbiol (Paris); 1982; 133(3):491-501. PubMed ID: 6762128
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the components of a commercial probiotic in gnotobiotic mice experimentally challenged with Salmonella enterica subsp. enterica ser. Typhimurium.
Maia OB; Duarte R; Silva AM; Cara DC; Nicoli JR
Vet Microbiol; 2001 Mar; 79(2):183-9. PubMed ID: 11230939
[TBL] [Abstract][Full Text] [Related]
6. Effects of yeast probiotic formulation on viability, revival and protection against infection with Salmonella enterica ssp. enterica serovar Typhimurium in mice.
Martins FS; Veloso LC; Arantes RM; Nicoli JR
Lett Appl Microbiol; 2009 Dec; 49(6):738-44. PubMed ID: 19780950
[TBL] [Abstract][Full Text] [Related]
7. [Invasion and growth of bacteria into cells: invasion of bacteria into the intestinal mucosa and establishment of infection].
Kokawa H
Nihon Ishikai Zasshi; 1972 Mar; 67(5):717-25. PubMed ID: 4622763
[No Abstract] [Full Text] [Related]
8. Saccharomyces cerevisiae strain 905 reduces the translocation of Salmonella enterica serotype Typhimurium and stimulates the immune system in gnotobiotic and conventional mice.
Martins FS; Rodrigues ACP; Tiago FCP; Penna FJ; Rosa CA; Arantes RME; Nardi RMD; Neves MJ; Nicoli JR
J Med Microbiol; 2007 Mar; 56(Pt 3):352-359. PubMed ID: 17314366
[TBL] [Abstract][Full Text] [Related]
9. Screening of yeasts as probiotic based on capacities to colonize the gastrointestinal tract and to protect against enteropathogen challenge in mice.
Martins FS; Nardi RM; Arantes RM; Rosa CA; Neves MJ; Nicoli JR
J Gen Appl Microbiol; 2005 Apr; 51(2):83-92. PubMed ID: 15942869
[TBL] [Abstract][Full Text] [Related]
10. Effect of the Escherichia coli EMO strain on experimental infection by Salmonella enterica serovar Typhimurium in gnotobiotic mice.
Lima-Filho JV; Vieira LQ; Arantes RM; Nicoli JR
Braz J Med Biol Res; 2004 Jul; 37(7):1005-13. PubMed ID: 15264007
[TBL] [Abstract][Full Text] [Related]
11. Saccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling events.
Mumy KL; Chen X; Kelly CP; McCormick BA
Am J Physiol Gastrointest Liver Physiol; 2008 Mar; 294(3):G599-609. PubMed ID: 18032477
[TBL] [Abstract][Full Text] [Related]
12. Prevention of Clostridium difficile induced mortality in gnotobiotic mice by Saccharomyces boulardii.
Corthier G; Dubos F; Ducluzeau R
Can J Microbiol; 1986 Nov; 32(11):894-6. PubMed ID: 3815159
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of the digestive microbiota in a gnotobiotic mouse model during antibiotic treatment: Influence of Saccharomyces boulardii.
Barc MC; Charrin-Sarnel C; Rochet V; Bourlioux F; Sandré C; Boureau H; Doré J; Collignon A
Anaerobe; 2008 Oct; 14(4):229-33. PubMed ID: 18511310
[TBL] [Abstract][Full Text] [Related]
14. [Live vaccines for the prevention of intestinal infections].
Sergeev VV; Kreynin LS; Lichoded VG; Elkina CU; Zukova LF; Kaverina KG
Arch Exp Veterinarmed; 1980; 34(1):87-9. PubMed ID: 6998403
[TBL] [Abstract][Full Text] [Related]
15. Quinine sulfate inhibits invasion of Salmonella typhimurium and Shigella flexneri: a preliminary study.
Wolf R; Grimaldi E; Donnarumma G; Greco R; Auricchio L; De Filippis A; Tufano MA
J Travel Med; 2005; 12(6):343-6. PubMed ID: 16343387
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of turkey cecal microflora in protecting day-old poults from Salmonella typhimurium challenge.
Reid CR; Barnum DA
Avian Dis; 1983; 27(3):632-43. PubMed ID: 6357184
[TBL] [Abstract][Full Text] [Related]
17. Antagonistic effect of extremely oxygen-sensitive clostridia from the microflora of conventional mice and of Escherichia coli against Shigella flexneri in the digestive tract of gnotobiotic mice.
Ducluzeau R; Ladire M; Callut C; Raibaud P; Abrams GD
Infect Immun; 1977 Aug; 17(2):415-24. PubMed ID: 330410
[TBL] [Abstract][Full Text] [Related]
18. Effect of Bifidobacterium longum ingestion on experimental salmonellosis in mice.
Silva AM; Barbosa FH; Duarte R; Vieira LQ; Arantes RM; Nicoli JR
J Appl Microbiol; 2004; 97(1):29-37. PubMed ID: 15186439
[TBL] [Abstract][Full Text] [Related]
19. Lactoferrin increases both resistance to Salmonella typhimurium infection and the production of antibodies in mice.
Drago-Serrano ME; Rivera-Aguilar V; Reséndiz-Albor AA; Campos-Rodríguez R
Immunol Lett; 2010 Nov; 134(1):35-46. PubMed ID: 20727369
[TBL] [Abstract][Full Text] [Related]
20. Intestinal bacterial flora and host defense mechanisms.
Ozawa A; Ohnishi N; Tazume S; Aiba Y; Watanabe K
Tokai J Exp Clin Med; 1986; 11 Suppl():65-79. PubMed ID: 2968005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
